Lahalak Medical PlatformDifferentiate Care

Medical Laboratories

Advanced Fabry Disease Screening

Globotriaosylceramide (GL-3) Analysis

Accurately measure GL-3 levels to assess Fabry disease, aiding in early diagnosis and monitoring treatment efficacy to protect vital organs like the heart and kidneys.

Trusted medical contentUpdated: 10-11-2026Views: 0LHL-6546

View service availability

Service typeLaboratory test

Duration10-15 minutes

Fasting / preparationFasting is not required

Home serviceAvailable

Medical notice: this information is for education and service understanding. It is not a diagnosis or a recommendation for an unnecessary procedure.

About this service

A laboratory test measuring GL-3 accumulation in dried blood spots. It serves as a critical biomarker for diagnosing Fabry disease and monitoring patient response to enzyme replacement therapy.

Clinical Significance

Detecting harmful lipid accumulation in cells.
Assessing the severity of Fabry disease.
Monitoring the efficacy of Enzyme Replacement Therapy (ERT).

Target Groups

Individuals with unexplained neurological symptoms.
Patients with idiopathic renal or cardiac issues.
First-degree relatives of known Fabry disease patients.

Testing Methodology

A few drops of blood are collected.
Sample is applied to a specialized filter paper (Dried Blood Spot).
The sample is sent to specialized metabolic laboratories for analysis.

What is included?

✓Blood sample collection
✓Specialized lab analysis (DBS)
✓Results report

Conditions and notices

Fasting is not required
Preferable to provide medical history regarding neurological or renal symptoms

Frequently Asked Questions

Short answers to the FAQs published with this service.

• What is Fabry disease and how does the GL-3 test detect it?

Fabry disease is a genetic disorder causing lipid buildup; the GL-3 test measures these lipids to evaluate the disease's presence.

• Is fasting required before the GL-3 analysis?

No, fasting is not required for this test, and it can be performed at any time of the day.

• How is the blood sample collected for this test?

The sample is collected via a standard blood draw or finger prick to apply blood spots onto special filter paper.

• Can this analysis be used to monitor treatment?

Yes, physicians use GL-3 levels as a biomarker to monitor how well the body is responding to enzyme therapy.

• When do GL-3 test results usually become available?

As it is a specialized test, results typically take between 7 to 14 business days.

• Is home sample collection available for this service?

Yes, Lahalak Medical Platform offers home collection services for your convenience.

Service resources and references

References and additional resources

Reference material and files associated with this service when available.

Scientific references

National Organization for Rare Disorders (NORD)
Journal of Medical Genetics

Labeeb & Search Tools

Let us help you

Use Labeeb smart tools to understand reports related to (Medical Laboratories), or search the platform directory directly.

Browse services alphabetically A-Z

LahaLak is here to help

Didn’t find the service?

We can help request the service and prepare your inquiry, or you can ask Labeeb to guide you to the most suitable category or service.

Phone call

Your opinion matters

Was this content helpful?

Have a note?

Important Notice:

Content on LahaLak is provided for educational purposes only. It is not a medical diagnosis, prescription, or substitute for consulting a qualified clinician. Medical decisions should not be made from this content alone.

Content reviewed according to the LahaLak Quality Charter.Editorial Policy & Medical Standards

View service availability

View availability

Medical Laboratories

Advanced Fabry Disease Screening

Globotriaosylceramide (GL-3) Analysis

Accurately measure GL-3 levels to assess Fabry disease, aiding in early diagnosis and monitoring treatment efficacy to protect vital organs like the heart and kidneys.

Trusted medical contentUpdated: 10-11-2026Views: 0LHL-6546

View service availability

Service typeLaboratory test

Duration10-15 minutes

Fasting / preparationFasting is not required

Home serviceAvailable

Medical notice: this information is for education and service understanding. It is not a diagnosis or a recommendation for an unnecessary procedure.

About this service

A laboratory test measuring GL-3 accumulation in dried blood spots. It serves as a critical biomarker for diagnosing Fabry disease and monitoring patient response to enzyme replacement therapy.

Clinical Significance

Detecting harmful lipid accumulation in cells.
Assessing the severity of Fabry disease.
Monitoring the efficacy of Enzyme Replacement Therapy (ERT).

Target Groups

Individuals with unexplained neurological symptoms.
Patients with idiopathic renal or cardiac issues.
First-degree relatives of known Fabry disease patients.

Testing Methodology

A few drops of blood are collected.
Sample is applied to a specialized filter paper (Dried Blood Spot).
The sample is sent to specialized metabolic laboratories for analysis.

What is included?

✓Blood sample collection
✓Specialized lab analysis (DBS)
✓Results report

Conditions and notices

Fasting is not required
Preferable to provide medical history regarding neurological or renal symptoms

Frequently Asked Questions

Short answers to the FAQs published with this service.

• What is Fabry disease and how does the GL-3 test detect it?

Fabry disease is a genetic disorder causing lipid buildup; the GL-3 test measures these lipids to evaluate the disease's presence.

• Is fasting required before the GL-3 analysis?

No, fasting is not required for this test, and it can be performed at any time of the day.

• How is the blood sample collected for this test?

The sample is collected via a standard blood draw or finger prick to apply blood spots onto special filter paper.

• Can this analysis be used to monitor treatment?

Yes, physicians use GL-3 levels as a biomarker to monitor how well the body is responding to enzyme therapy.

• When do GL-3 test results usually become available?

As it is a specialized test, results typically take between 7 to 14 business days.

• Is home sample collection available for this service?

Yes, Lahalak Medical Platform offers home collection services for your convenience.

Service resources and references

References and additional resources

Reference material and files associated with this service when available.

Scientific references

National Organization for Rare Disorders (NORD)
Journal of Medical Genetics

Service availability

Choose a provider and branch

Each provider has one service price, then you choose from its available branches.

Labeeb & Search Tools

Let us help you

Use Labeeb smart tools to understand reports related to (Medical Laboratories), or search the platform directory directly.

Browse services alphabetically A-Z

LahaLak is here to help

Didn’t find the service?

We can help request the service and prepare your inquiry, or you can ask Labeeb to guide you to the most suitable category or service.

Phone call

Related services

Services you might also like

Medical service

Hope Test for SMA

An advanced genetic test for early detection of SMA mutations, ensuring your child receives an accurate diagnosis and timely treatment for a healthier future.

Starting from6,703.2 SAR

View service

Medical service

Fanconi Anemia Genetic Screening

A specialized genetic test detecting large-scale deletions or duplications in genes associated with Fanconi Anemia, providing essential data for accurate diagnosis and comprehensive family genetic counseling.

Starting from12,100 SAR

View service

Medical service

Genetic Health Check for Children

This analysis assists in the accurate molecular diagnosis of Beckwith-Wiedemann syndrome by examining genetic changes, contributing to early and integrated healthcare for the affected child.

Starting from2,645 SAR

View service

Medical service

Identify Albinism Genetic Causes

A comprehensive genetic panel analyzing genes linked to oculocutaneous and ocular albinism, identifying specific mutations to support clinical diagnosis and inform future healthcare decisions for families.

Starting from4,067.55 SAR

View service

Your opinion matters

Was this content helpful?

Have a note?

Important Notice:

Content reviewed according to the LahaLak Quality Charter.Editorial Policy & Medical Standards

View service availability